. . . . . . . . . . . . . . . . "kin(p(HGNC:CSNK2A1)) -> p(HGNC:MYC)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Pharmacologic inhibition of CK2 activity in cell lines established from CK2alpha transgenic T cell lymphomas reduces their proliferation and concomitantly with this, the steady state levels of c-myc protein decline. This is caused by accelerated c-myc protein turnover, which occurs in a proteasome-dependent manner." . . "Selventa" . . . . "2014-07-03T14:31:52.055+02:00"^^ . . .